Trial intelligence / Profile preview

Intrathecal ropivacaine with dexmedetomidine or fentanyl for lower limb orthopedic surgery

IRCT20130311012782N41Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Apr 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in postoperative pain comparing Ropivacaine + dexmedetomidine, Ropivacaine + fentanyl and Ropivacaine control (3 arms). Primary endpoints: Time to reach sensory block, Time to motor block and 5 more. Started Apr 2020; status: completed.

02

Drugs

ropivacainedexmedetomidinefentanyl
03

Conditions

postoperative pain

Beyond the preview

Go deeper on IRCT20130311012782N41.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20130311012782N41.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call